Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. - Xu, Yitian; Wang, Lihua; Zimmerman, Matthew D.; Chen, Kai-Yuan; Huang, Lu; Fu, Dah-Jiun; Kaya, Firat; Rakhilin, Nikolai; Nazarova, Evgeniya V.; Bu, Pengcheng; Dartois, Veronique; Russell, David G.; et al. (PLoS Pathogens, 2018)